Honkamp Krueger Financial Services »

Regeneron Pharmaceuticals shares owned by Honkamp Krueger Financial Services

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Honkamp Krueger Financial Services from 13F filings

Historical chart of Honkamp Krueger Financial Services investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Honkamp Krueger Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Honkamp Krueger Financial Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $456k 474 962.49
2023-12-31 $280k 319 878.29
2023-09-30 $263k 319 822.96
2023-06-30 $228k 317 718.54
2023-03-31 $261k 317 821.67
2022-12-31 $229k 317 721.49
2022-09-30 $218k 317 687.70
2022-06-30 $217k 367 591.28
2022-03-31 $256k 367 697.55
2021-12-31 $232k 367 632.15
2021-09-30 $222k 367 604.90
2018-03-31 $6.0k 18 333.33